Abstract:
PURPOSE: A vaccine for preventing H5N1 serotype highly pathogenic avian influenza is provided to prevent recurrence of H5type and disease. CONSTITUTION: A method for manufacturing H5N1 serotype highly pathogenic avian influenza virus strain(KCTC 11405BP) comprises: a step of amplifying a highly pathogenic gene from A/Vietnam/1203/2004 (H5N1) strain; a step of transforming by recombination of the gene; a third step of amplifying the gene from A/PR/8/34 (H1N1); a step of culturing plasmid in Vero cells; and a step of inoculating culture supernatant to specific pathogen free(SPF) a hatching egg. The H5N1 serotype highly pathogenic avian influenza virus strain(KCTC 11405BP) contains the highly pathogen-inducing gene. The gene contains HA, NA, PB2, PB1, PA, NP, M and NS.
Abstract:
The present invention relates to a novel use of a Potentilla chinensis SER extract for effectively preventing and treating an influenza viral infection. The Potentilla chinensis SER according to the present invention has excellent effects in decreasing and controlling the proliferation of influenza viruses such as the human infectious disease highly pathogenic influenza virus (A/Vietnam/HN36285/2010 H5N1), the new flu virus (A/California/07/2009 H1N1), the seasonal flu virus (A/Wisconsin/15/09 H3N2), or the seasonal flu virus (B/Brisbane/60/2008) so as to be usefully used as an agent for treating influenza. The Potentilla chinensis SER extract is stable in vivo so as to be used as a material for a functional health food.
Abstract:
PURPOSE: An oriental medicinal material for enhancing anticancer activity is provided to show excellent anticancer effect. CONSTITUTION: A method for manufacturing an oriental medicinal material with anticancer activity comprises the steps of: reacting non-arsenic minerals and Erigeron Canadensis L. mixed in a weight ratio of 0.7:1-1:0.7; inputting the mixture into a pottery and sealing; and heating the pottery. The non-arsenic mineral includes orpiment and/or arsenic trioxide. [Reference numerals] (AA) Negative control group; (BB) Erigeron canadensis L.; (CC) Amantadine